====== Ibrutinib 1μM R07 exp372 ====== ==== Mechanism of Action ==== Inhibits BTK * **Class / Subclass 1:** Signal Transduction / Kinase Inhibitor ==== Technical Notes ==== * **PubChem Name:** %%Ibrutinib%% * **Synonyms:** PCI-32765 * **CAS #:** 936563-96-1 * **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/24821094|24821094]] * **IUPAC:** %%1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one%% * **INCHI Name:** InChI=1S/C25H24N6O2/c1-2-21(32)30-14-6-7-18(15-30)31-25-22(24(26)27-16-28-25)23(29-31)17-10-12-20(13-11-17)33-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H2,26,27,28)/t18-/m1/s1 * **INCHI Key:** XYFPWWZEPKGCCK-GOSISDBHSA-N * **Molecular Weight:** 440.5 * **Canonical SMILES:** C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N * **Isomeric SMILES:** C=CC(=O)N1CCC[C@H](C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N * **Molecular Formula:** C25H24N6O2 {{:chemogenomics:structures:chem-0219.svg?nolink}} * **Supplier Name:** Med Chem Express * **Catalog #:** HY-10997 * **Lot #:** 11159 * **HRMS (ESI-TOF) m/z:** (M+H)+ Calcd for C25H24N6O2 441.20335; found 441.20542 * **Platform ID:** Ibrutinib * **Min:** 9.9340; **Max:** 89.6423 {{:chemogenomics:dose_response:dr_434.png?nolink&500 |}} \\ \\ \\ \\ |< 300px 100px 200px >| ^ IC ^ Concentration (µM) ^ | IC10 |N/A | | IC20 |6.9040 | | IC30 |9.0387 | | IC40 |10.9023 | | IC50 |12.8362 | | IC60 |N/A | | IC70 |N/A | | IC80 |N/A | | IC90 |N/A | \\ ==== Screen Summary ==== * **Round**: 07 * **Dose**: 1µM * **Days of incubation**: 8 * **Doublings**: 6.5 * **Numbers of reads**: 19801915 ==== Screen Results ==== ^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^ |0/0|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/Ibrutinib_1uM_Round-7_exp372.txt|Scores]]|||||| {{:chemogenomics:cranks_plots:exp372.png?nolink}} ^Gene^CRANKS Score^FDR^ |[[:human_genes:M:MTHFS|MTHFS]]|-2.53|0.30| |[[:human_genes:K:KRTAP10-4|KRTAP10-4]]|-2.33|0.56| |[[:human_genes:M:MTR|MTR]]|-2.30|0.41| |[[:human_genes:V:VPS25|VPS25]]|-2.25|0.61| |[[:human_genes:O:OR1J1|OR1J1]]|-2.24|0.41| |[[:human_genes:U:UHRF1|UHRF1]]|-2.19|0.41| |[[:human_genes:A:ARFRP1|ARFRP1]]|-2.18|0.41| |[[:human_genes:Z:ZNF117|ZNF117]]|-2.17|0.41| |[[:human_genes:C:CAPZA2|CAPZA2]]|-2.14|0.41| |[[:human_genes:Z:ZDHHC5|ZDHHC5]]|-2.12|0.46| |[[:human_genes:D:DCLRE1B|DCLRE1B]]|-2.10|0.41| |[[:human_genes:M:MTHFD1L|MTHFD1L]]|-2.10|0.41| |[[:human_genes:P:PIFO|PIFO]]|-2.09|0.41| |[[:human_genes:V:VEZT|VEZT]]|-2.07|0.41| |[[:human_genes:T:TCF4|TCF4]]|-2.06|0.41| |[[:human_genes:I:IL1RAP|IL1RAP]]|-2.05|0.41| |[[:human_genes:M:MAS1|MAS1]]|-2.03|0.41| |[[:human_genes:S:SLC25A32|SLC25A32]]|-2.00|0.57| |[[:human_genes:T:TCOF1|TCOF1]]|-1.99|0.57| |[[:human_genes:A:ADSL|ADSL]]|-1.96|0.61| |[[:human_genes:S:SLC46A3|SLC46A3]]|-1.94|0.56| |[[:human_genes:T:TFEC|TFEC]]|-1.94|0.56| |[[:human_genes:P:PDXK|PDXK]]|-1.93|0.56| |[[:human_genes:K:KDM8|KDM8]]|-1.93|0.61| |[[:human_genes:M:MAGEC3|MAGEC3]]|-1.91|0.61| |[[:human_genes:C:CEPT1|CEPT1]]|-1.91|0.56| |[[:human_genes:F:FBXO11|FBXO11]]|-1.90|0.56| |[[:human_genes:L:LIG4|LIG4]]|-1.88|0.61| |[[:human_genes:P:PLD2|PLD2]]|-1.87|0.57| |[[:human_genes:R:RTCB|RTCB]]|-1.86|0.61| |[[:human_genes:R:RPF1|RPF1]]|1.89|0.68| |[[:human_genes:P:POLD2|POLD2]]|1.90|0.73| |[[:human_genes:Y:YPEL5|YPEL5]]|1.91|0.68| |[[:human_genes:A:ACSF2|ACSF2]]|1.91|0.68| |[[:human_genes:T:TMEM135|TMEM135]]|1.92|0.68| |[[:human_genes:S:SYNE2|SYNE2]]|1.92|0.68| |[[:human_genes:M:MYC|MYC]]|1.93|0.74| |[[:human_genes:D:DUSP2|DUSP2]]|1.94|0.68| |[[:human_genes:N:NPIPB3|NPIPB3]]|1.97|0.77| |[[:human_genes:T:TGFBR3|TGFBR3]]|1.98|0.68| |[[:human_genes:A:ABHD11|ABHD11]]|2.00|0.68| |[[:human_genes:G:GAS1|GAS1]]|2.01|0.68| |[[:human_genes:A:ANXA8L2|ANXA8L2]]|2.01|0.68| |[[:human_genes:A:ACYP1|ACYP1]]|2.02|0.68| |[[:human_genes:A:ANP32C|ANP32C]]|2.02|0.73| |[[:human_genes:S:SLC1A2|SLC1A2]]|2.02|0.68| |[[:human_genes:N:NHP2L1|NHP2L1]]|2.02|0.74| |[[:human_genes:S:SGCG|SGCG]]|2.04|0.68| |[[:human_genes:C:C2orf48|C2orf48]]|2.07|0.68| |[[:human_genes:T:TNNC1|TNNC1]]|2.07|0.68| |[[:human_genes:K:KMT2B|KMT2B]]|2.07|0.68| |[[:human_genes:C:CDC73|CDC73]]|2.07|0.71| |[[:human_genes:G:GOLPH3|GOLPH3]]|2.09|0.68| |[[:human_genes:P:PCNA|PCNA]]|2.09|0.74| |[[:human_genes:L:LRR1|LRR1]]|2.17|0.68| |[[:human_genes:S:SNRPF|SNRPF]]|2.29|0.74| |[[:human_genes:C:COPE|COPE]]|2.30|0.74| |[[:human_genes:P:PSMC3|PSMC3]]|2.35|0.73| |[[:human_genes:Z:ZNF714|ZNF714]]|2.49|0.39| |[[:human_genes:A:ATP1A3|ATP1A3]]|2.54|0.39| ^Screen^Correlation^Plot^ |[[:results:exp421|VHL-ligand-1 20μM R07 exp421]]|0.065|| {{:chemogenomics:comparison_plots:exp372_vs_exp421.png?nolink |}} ^GO Term^Fold Change^Genes^ |pteridine-containing compound metabolic process|76.40|MTHFS,MTR,MTHFD1L,SLC25A32| |water-soluble vitamin metabolic process|40.83|MTHFS,MTR,SLC25A32,PDXK| No GO term hits below threshold. (FDR <0.05)